Details of the Drug

General Information of Drug (ID: DMWK26Q)

Drug Name
EPX-200
Indication
Disease Entry ICD 11 Status REF
Dravet syndrome 8A61.11 Phase 2 [1]
Cross-matching ID
TTD ID
D0H4GU

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
5-HT receptor (5HTR) TT85JO3 NOUNIPROTAC Modulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)